All updates
All updates
today 36文献与产业新闻评分1111 文献与产业新闻评分1919 Fierce Pharma Asia—Roche, GSK, Novartis billion-dollar deals; More MFN sign-ups; Akeso’s OS win
文献与产业新闻评分1212 Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
文献与产业新闻评分66 Novartis puts MS advocacy on the podium through social media partnership with British Olympian
文献与产业新闻评分1717 STAT+: OpenEvidence launches new family of AI models
中文产业新闻精选Chinese source评分6161 康诺思腾获美敦力约7亿美元战略投资并获Sentire海外分销权
文献与产业新闻评分3636 Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal
文献与产业新闻精选评分6464 GSK pens $1.3B Hutchmed deal for early-stage KRAS-EGFR cancer asset
文献与产业新闻评分2525 K2 Therapeutics: Spreading bets across range of Asia-sourced assets
文献与产业新闻评分88 CMI boosts medical affairs capabilities with new specialty communications unit
文献与产业新闻评分3434 Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
文献与产业新闻评分2525 Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland
文献与产业新闻评分1616 STAT+: ARPA-H funds biotechs working on custom RNA therapies
文献与产业新闻评分1414 STAT+: How a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’
中文产业新闻精选Chinese source评分6363 先声再明就 SIM0660 与罗氏达成全球独家授权合作
中文产业新闻精选Chinese source评分6262 先声再明与罗氏就CD79a/CD19/CD3三抗SIM0660达成超15亿美元全球授权合作
中文产业新闻精选Chinese source评分6464 康诺思腾获美敦力约7亿美元战略投资，共拓Sentire腔镜手术机器人海外市场
中文产业新闻精选Chinese source评分6262 先声再明与罗氏就三特异性抗体SIM0660签署全球独家授权许可协议
中文产业新闻精选Chinese source评分6262 先声药业三抗SIM0660以最高15.3亿美元授权罗氏全球权益
中文产业新闻精选Chinese source评分6363 康诺思腾获美敦力7亿美元战略投资
文献与产业新闻精选评分4141 TScan axes 75% of workforce to make room for solid tumor programs
文献与产业新闻评分3030 Cellares downsizes New Jersey operations after losing BMS cell therapy contract
文献与产业新闻精选评分4040 Novartis inks $3.2B subcutaneous drug delivery deal with Alteogen
文献与产业新闻评分99 Galderma, Novartis dominated ad space last NFL season with most effective ads: report
文献与产业新闻评分1717 New roles at Vertex amid Crinetics integration
中文产业新闻精选Chinese source评分6666 迪哲医药与阿斯利康舒沃替尼全球许可协议生效，6亿美元首付款即将入账
中文产业新闻精选Chinese source评分6262 迪哲医药递交港股招股书，与阿斯利康签6亿美元首付款授权
文献与产业新闻评分77 Rising Stars: Genentech’s Tiffany William brings a 'fail fast, learn fast' marketing mentality
文献与产业新闻评分4848 Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
文献与产业新闻评分4747 ArsenalBio sheds most of staff in pivot to in vivo CAR-T
文献与产业新闻评分2424 Novocure hit by cyberattack exposing patient data
文献与产业新闻评分1010 Bausch + Lomb survey reveals low dry eye awareness for perimenopausal, postmenopausal women
Cancer Discovery评分2121 Nonprofit Acquires Abandoned Leukemia Drug Supply
文献与产业新闻评分66 Emergent re-ups Narcan education push across US, Canada on overdose awareness day
文献与产业新闻精选评分5555 Lilly’s deal spree continues with Merida takeout: Deals Report
文献与产业新闻评分3434 STAT+: Can buying a drug patent application be seen as a bid to prolong a monopoly?
文献与产业新闻精选评分5757 Ascendis to pay 20% Yuviwel royalties in patent settlement with BioMarin
中文产业新闻Chinese source评分6565 直观外科IG1000柔性消化内镜手术机器人获FDA批准
中文产业新闻Chinese source评分6060 三星生物$21.7亿配股筹资并购PolyPeptide